Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#41 / 110 Total
OPY - Oppenheimer Holdings Inc - Stock Price Chart
TickerOPY [NYSE]
CompanyOppenheimer Holdings Inc
CountryUSA
IndustryCapital Markets
Market Cap546.87MEPS (ttm)3.71
P/E14.28EPS this Y-
Forward P/E-EPS next Y-
PEG0.95EPS past 5Y4.75%
P/S0.43EPS next 5Y15.00%
P/B0.68EPS Q/Q93.83%
Dividend1.13%Sales Q/Q9.78%
Insider Own43.73%Inst Own33.70%
Insider Trans-0.09%Inst Trans-7.96%
Short Float0.69%Earnings-
Analyst Recom1.00Target Price37.00
Avg Volume44.87K52W Range32.82 - 58.35
Oppenheimer Holdings, Inc. engages as a middle-market investment bank and full-service broker-dealer. It operates through the following segments: Private Client, Asset Management, Capital Markets, and Corporate/Other. The Private Client segment consists of commissions and a proportionate amount of fee income earned on assets under management (AUM), net interest earnings on client margin loans and cash balances, fees from money market funds, custodian fees, net contributions from stock loan activities and financing activities, and direct expenses. The Asset Management segment consists of fee income earned on AUM from investment management services of Oppenheimer Asset Management Inc. The Capital Markets segment offers investment banking, institutional equities sales, trading, and research, taxable fixed income sales, trading, and research, public finance, and municipal trading. The Corporate/Other segment pertains to legal, compliance, accounting, and internal audit activities. The company was founded in 1881 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BEHRENS EVANDirectorMay 10 '24Sale43.654,125180,0564,875May 10 04:12 PM
BEHRENS EVANDirectorSep 01 '23Sale38.435,000192,1506,000Sep 05 04:08 PM
BEHRENS EVANDirectorAug 31 '23Sale38.357,500287,62511,000Sep 05 04:08 PM
VRPX - Virpax Pharmaceuticals Inc - Stock Price Chart
TickerVRPX [NASD]
CompanyVirpax Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap6.64MEPS (ttm)-14.42
P/E-EPS this Y71.01%
Forward P/E-EPS next Y54.79%
PEG-EPS past 5Y-20.69%
P/S-EPS next 5Y-
P/B-EPS Q/Q-111.83%
Dividend-Sales Q/Q-
Insider Own10.99%Inst Own0.03%
Insider Trans0.00%Inst Trans-5.18%
Short Float14.76%EarningsMay 13/a
Analyst Recom1.00Target Price3.00
Avg Volume6.05M52W Range0.46 - 9.50
Virpax Pharmaceuticals, Inc. is a preclinical stage biopharmaceutical company, which engages in the development of branded, non-addictive pain management products. Its products include metered-dose spray, liposomal gel encapsulates, and intranasal spray. The company was founded by Anthony P. Mack and Jeffrey A. Gudin in 2016 and and is headquartered in Berwyn, PA.
COSM - Cosmos Health Inc - Stock Price Chart
TickerCOSM [NASD]
CompanyCosmos Health Inc
CountryGreece
IndustryMedical Distribution
Market Cap19.81MEPS (ttm)-4.22
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-22.04%
P/S0.40EPS next 5Y-
P/B0.34EPS Q/Q86.15%
Dividend-Sales Q/Q6.72%
Insider Own9.16%Inst Own3.57%
Insider Trans4.02%Inst Trans-97.68%
Short Float1.85%Earnings-
Analyst Recom1.00Target Price4.00
Avg Volume2.10M52W Range0.47 - 2.05
Jul-25-24 02:45PM Cosmos Health Successfully Submits Tender for C-Scrub Wash Chlorhexidine 4% to Supply NHS Scotland (ACCESSWIRE) +5.79%
11:40AM Cosmos Health Signs Distribution Agreement with ProMed Trading for Its Sky Premium Life Food Supplements in Qatar (ACCESSWIRE)
Jul-24-24 10:55AM Cosmos Health Updates on Contract Manufacturing Division; Completes Phase I of Production Capacity Expansion, Positioned to Generate Over $10M in Annual Gross Profit at Full Capacity (ACCESSWIRE)
Jul-19-24 11:40AM Cosmos Health Regains Compliance with Nasdaq Minimum Bid Price Rule (ACCESSWIRE)
Jul-18-24 03:45PM Cosmos Health's Cana Secures Additional Contract Manufacturing Agreement with Provident Pharmaceuticals for 700,000 Units, Bringing Total Order Book to 5.02 Million Units (ACCESSWIRE) -10.36%
Jul-10-24 03:45PM Cosmos Health Advances Commercialization of CCX0722 Weight Management Solution with Completion of Pilot Production and Scale-Up Phases; Significant Step Towards Entering $143Bn Global Market (ACCESSWIRE)
Jul-09-24 02:00PM Cosmos Health's Cana Secures Contract Manufacturing Agreement with Australia's Humacology for up to 500,000 CBD Units Annually (ACCESSWIRE)
Jul-03-24 01:05PM Cosmos Health's Cana Laboratories Completes Facility Upgrades and Secures Contract Manufacturing Agreement with Provident Pharmaceuticals for 4.32 Million Vials of DE3-SOLE (ACCESSWIRE) -10.89%
Jul-02-24 03:30PM Cosmos Health Expands Collaboration with Papaellinas in Cyprus; Sky Premium Life Sales Expected to More Than Double to 150,000 Units Over Next 12 Months (ACCESSWIRE) -8.18%
Jul-01-24 11:20AM Cosmos Health Signs Distribution Agreement with ZENDON s.r.o. in Slovakia, Hungary, Poland, and Czechia for Its Sky Premium Life Nutraceutical Products; Gains Access to More than 6,000 Stores of Leading Pharmacy and Retail Chains (ACCESSWIRE) +5.77%
Cosmos Health, Inc. is a pharmaceutical company, which engages in the importation, exportation, distribution, and sale of pharmaceutical products. It is also involved in the research and development of its business units, and acquisition of pharmaceutical companies. The firm offers over-the-counter drugs, branded and generic medicines, and dietary and vitamin supplements. The company was founded on July 21, 2009 and is headquartered in Thessaloniki, Greece.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Siokas GrigoriosChief Executive OfficerFeb 16 '24Buy0.8360,00049,8061,394,597Feb 21 10:21 AM
Siokas GrigoriosChief Executive OfficerOct 12 '23Buy23.666,712158,8061,334,597Oct 12 09:43 AM
EHGO - Eshallgo Inc - Stock Price Chart
TickerEHGO [NASD]
CompanyEshallgo Inc
CountryChina
IndustryBusiness Equipment & Supplies
Market Cap34.99MEPS (ttm)0.02
P/E67.65EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S2.00EPS next 5Y-
P/B3.24EPS Q/Q29.69%
Dividend-Sales Q/Q-10.39%
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume144.30K52W Range1.51 - 4.40
Jul-03-24 05:08PM Eshallgo Inc Announces Closing of Initial Public Offering (PR Newswire) -19.94% -17.62%
Jul-01-24 07:53PM Eshallgo Inc Announces Pricing of Initial Public Offering (PR Newswire)
Eshallgo, Inc. operates as a holding company, which through its subsidiaries and controlled entities engages in the sale and lease of office equipment and related maintenance services. The company was founded by Zhi Dan Mao and Qi Wei Miao in 2015 and is headquartered in Shanghai, China.
ADN - Advent Technologies Holdings Inc - Stock Price Chart
TickerADN [NASD]
CompanyAdvent Technologies Holdings Inc
CountryUSA
IndustryUtilities - Renewable
Market Cap11.65MEPS (ttm)-52.69
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-1240.46%
P/S2.19EPS next 5Y-
P/B0.29EPS Q/Q11.61%
Dividend-Sales Q/Q-47.31%
Insider Own17.18%Inst Own5.96%
Insider Trans0.00%Inst Trans-50.89%
Short Float4.22%Earnings-
Analyst Recom3.00Target Price13.50
Avg Volume39.31K52W Range2.70 - 27.72
Advent Technologies Holdings, Inc. operates as an advanced materials and technology development company. It develops, manufactures and assembles hydrogen fuel cell components. The company was founded on June 18, 2018 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Brackman Kevin L.CFOSep 06 '23Sale0.5327,77114,746176,477Sep 08 05:00 PM
Gregoriou VassiliosCEO, ChairSep 06 '23Sale0.5314,1577,5176,367,669Sep 08 05:00 PM
GDTC - CytoMed Therapeutics Ltd - Stock Price Chart
TickerGDTC [NASD]
CompanyCytoMed Therapeutics Ltd
CountrySingapore
IndustryBiotechnology
Market Cap20.89MEPS (ttm)-0.27
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B2.45EPS Q/Q9.49%
Dividend-Sales Q/Q-
Insider Own59.01%Inst Own0.00%
Insider Trans0.00%Inst Trans-
Short Float0.82%EarningsMay 29
Analyst Recom1.00Target Price5.00
Avg Volume71.92K52W Range1.88 - 5.50
Jul-17-24 07:00AM Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now (GlobeNewswire) +14.29%
07:00AM CytoMed Therapeutics Acquires Cord Blood Banking Licence and Assets to Entrench Its Strategy in Allogeneic, Off-the-shelf Donor-derived Gamma Delta (?d) T Cells Technology for Solid and Liquid Cancers (GlobeNewswire)
07:00AM CytoMed Therapeutics Acquires Cord Blood Banking Licence and Assets to Entrench Its Strategy in Allogeneic, Off-the-shelf Donor-derived Gamma Delta ( ) T Cells Technology for Solid and Liquid Cancers (GlobeNewswire)
Jul-16-24 07:00AM Presenting on the Emerging Growth Conference 73 Day 1 on July 17 Register Now (GlobeNewswire)
Mar-20-24 08:30AM CytoMed Diversifies into Regenerative Medicine after Research Collaboration with Singapore's Sengkang General Hospital to Test Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Regeneration (ACCESSWIRE) -5.60%
Mar-18-24 06:00AM CytoMed Therapeutics to Launch Complimentary Cell Banking for Qualified Shareholders for Future Precision Therapies (GlobeNewswire) +5.63%
Mar-04-24 05:00AM CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair (GlobeNewswire)
Jan-29-24 07:00AM Malaysian Patent Granted for CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology (GlobeNewswire)
Dec-05-23 07:30AM CytoMed Therapeutics Signs HOA and MOU to Advance Research on Allogeneic Gamma Delta T Cell Technology (PR Newswire)
Nov-17-23 09:21AM CytoMed Therapeutics Reports First Half 2023 Financial Report and Provides Corporate Update (PR Newswire) -8.60%
CytoMed Therapeutics Ltd. is a biopharmaceutical company, which engages in the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy, and undertaking the research and development of immune cell and stem cell-based therapy. It operates through the Malaysia and Singapore geographical segments. The company was founded by Chee Kong Choo on March 9, 2018 and is headquartered in Singapore.
NC - Nacco Industries Inc. - Stock Price Chart
TickerNC [NYSE, RUT]
CompanyNacco Industries Inc.
CountryUSA
IndustryThermal Coal
Market Cap230.06MEPS (ttm)-5.44
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S1.06EPS next 5Y-
P/B0.60EPS Q/Q-19.71%
Dividend2.85%Sales Q/Q6.28%
Insider Own57.98%Inst Own32.54%
Insider Trans-0.04%Inst Trans-1.33%
Short Float0.63%EarningsJul 31/a
Analyst Recom-Target Price-
Avg Volume16.89K52W Range27.26 - 38.66
NACCO Industries, Inc. is a holding company, which engages in the management of surface mines that supply coal to power generation companies. It operates through the following segments: Coal Mining, North American Mining (NAMining), and Minerals Management. The Coal Mining segment includes surface coal mines under long-term contracts with power generation companies and activated carbon producers. The NAMining segment offers value-added contract mining and other services for producers of aggregates, lithium, and other minerals. The Minerals Management segment focuses on the development of oil, gas, and coal reserves. The company was founded on February 18, 1986 and is headquartered in Cleveland, OH.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Maxwell Thomas ASVP Finance and TreasurerJun 13 '24Sale32.031,03433,1157,800Jun 17 02:43 PM
Maxwell Thomas ASVP Finance and TreasurerMar 13 '24Sale29.6486625,6688,834Mar 15 11:20 AM
COE - 51 Talk Online Education Group ADR - Stock Price Chart
TickerCOE [AMEX]
Company51 Talk Online Education Group ADR
CountrySingapore
IndustryEducation & Training Services
Market Cap68.71MEPS (ttm)-2.64
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y26.59%
P/S2.20EPS next 5Y-
P/B-EPS Q/Q-52.19%
Dividend-Sales Q/Q70.14%
Insider Own16.57%Inst Own2.82%
Insider Trans0.00%Inst Trans-
Short Float0.06%EarningsJun 12/b
Analyst Recom1.00Target Price36.49
Avg Volume14.51K52W Range6.00 - 19.75
51Talk Online Education Group engages in the operation of an online education platform in China. It operates under the China and Philippines geographical segments. Its online and mobile education platforms enable students across China to take live interactive english lessons with overseas foreign teachers on demand. The company was founded by Jia Jia Huang, Ting Shu, and Li Ming Zhang in July 2011 and is headquartered in Singapore.
XWEL - XWELL Inc - Stock Price Chart
TickerXWEL [NASD]
CompanyXWELL Inc
CountryUSA
IndustryDiagnostics & Research
Market Cap8.69MEPS (ttm)-5.93
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y66.28%
P/S0.27EPS next 5Y20.00%
P/B0.82EPS Q/Q54.57%
Dividend-Sales Q/Q23.55%
Insider Own11.36%Inst Own7.20%
Insider Trans0.06%Inst Trans-
Short Float1.93%EarningsApr 16/a
Analyst Recom1.00Target Price7.00
Avg Volume17.96K52W Range1.26 - 6.00
XWELL, Inc. provides global travel health and wellness services. It operates through the following segments: XpresSpa, XpresTest, Naples Wax Center, Treat, and Corporate & Other. The XpresSpa segment offers travelers premium spa services, including massage, nail and skin care, as well as spa and travel products. The XpresTest segment deals with diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public. The Naples Wax Center segment is focused on the products and service offerings from face and body waxing to a range of skincare and cosmetic products. The Treat segment is a wellness brand that provides access to wellness services for travelers at on-site centers. The company was founded by Jonathan Medved and David Goldfarb on January 9, 2006 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wizenberg Gaelle SandraDirectorMay 07 '24Buy1.85199368299Jul 22 08:47 AM
Wizenberg Gaelle SandraDirectorApr 26 '24Buy1.83100183100Jul 22 08:47 AM
MSBI - Midland States Bancorp Inc - Stock Price Chart
TickerMSBI [NASD, RUT]
CompanyMidland States Bancorp Inc
CountryUSA
IndustryBanks - Regional
Market Cap515.73MEPS (ttm)1.97
P/E12.20EPS this Y-9.83%
Forward P/E7.97EPS next Y12.55%
PEG1.74EPS past 5Y12.36%
P/S1.07EPS next 5Y7.00%
P/B0.65EPS Q/Q-76.77%
Dividend5.10%Sales Q/Q1.52%
Insider Own6.25%Inst Own64.67%
Insider Trans-0.60%Inst Trans-1.32%
Short Float0.97%EarningsJul 25/a
Analyst Recom3.00Target Price24.88
Avg Volume100.11K52W Range19.85 - 28.47
Midland States Bancorp, Inc. is a bank holding company which engages in the provision of commercial and consumer banking products and services. It operates through the following segments: Banking, Wealth Management, and Other. The Banking segment offers financial products and services such as loans, mortgage loan sales and servicing, letters of credit, deposit products, merchant services, and corporate treasury management services. The Wealth Management segment consists of trust and fiduciary services, brokerage, and retirement planning services. The Other segment includes the operating results of the parent company, the captive insurance business unit, and the elimination of intercompany transactions. The company was founded in 1988 and is headquartered in Effingham, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Tucker Douglas J.SVP Corporate CounselJul 17 '24Option Exercise23.0011,566266,01844,437Jul 18 04:00 PM
McDonnell Jeffrey MDirectorJun 13 '24Buy21.802,29049,92224,245Jun 14 12:35 PM
Mefford Jeffrey S.PresidentJun 12 '24Option Exercise18.002,96153,29848,968Jun 13 04:23 PM
Spring Donald J.Chief Accounting OfficerJun 12 '24Sale22.076,661146,9815,354Jun 13 04:22 PM
Spring Donald J.Chief Accounting OfficerJun 11 '24Sale22.001,19726,33812,015Jun 13 04:22 PM
1234567891011